Flora Growth (FLGC) Stock: Buy, Sell, or Hold?
FLGC - Flora Growth Corp. Common Stock
$8.95
-2.02 (-18.41%)
âŧ
5d:
+32.2%
30d:
+22.94%
90d:
-23.31%
WAIT
LOW Confidence
Analysis Updated: Jan 28, 2026 12:00 AM ET
Get Alerted When FLGC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: FLGC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: FLGC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: FLGC is currently trading at $8.95, which is considered fair based on recent price action.
Technical Outlook: Technically, FLGC is in a strong downtrend. Immediate support is located at $6.10, while resistance sits at $13.10. Short-term momentum is weak, with the stock down 18.4% recently.
Market Sentiment: FLGC scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+235.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FLGC is in a strong downtrend. Immediate support is located at $6.10, while resistance sits at $13.10. Short-term momentum is weak, with the stock down 18.4% recently.
Market Sentiment: FLGC scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+235.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
43/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
76.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-18.4%)
- BULLISH: Trading 235.2% below Wall St target ($30.00)
- WARNING: Composite score 43/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$6.10
Resistance Level
$13.10
Current Trend
Strong Downtrend
Technical data as of
Jan 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.52
Wall Street Target
$30.00
(+235.2%)
Revenue Growth (YoY)
34.7%
Profit Margin
-27.7%
Share FLGC Analysis
Share this live FLGC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (FLGC)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jan 29, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits user with 145 followers anticipates $FLGC's market cap to exceed 300 Million and believes the stock is going to triple digits, despite the current share price. No recent news articles were available.
Key Retail Themes:
Bullish outlook
Anticipated market cap growth
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 09, 2026 3:51 AM ET
Data refreshes hourly during market hours. Next update: 4:51 AM
Data refreshes hourly during market hours. Next update: 4:51 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FLGC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences IâĻ |
STRONG BUY
29 analysts |
$208 | 24 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 41 HOLD |
|
AQST
Aquestive Therapeutics IâĻ |
STRONG BUY
9 analysts |
$9 | 58 HOLD |
|
TEVA
Teva Pharma Industries LâĻ |
STRONG BUY
15 analysts |
$49 | 34 SELL |
|
ELAN
Elanco Animal Health |
STRONG BUY
16 analysts |
$31 | 33 SELL |
